· Cigna will
waive co-pays, coinsurance, or deductibles associated with
COVID-19 testing for customers enrolled in Medicare Advantage, as
well as fully-insured employer-sponsored plans in the U.S.,
Medicaid, and Individual & Family plans available through the
Affordable Care Act.
· The Centers
for Disease Control and Prevention (CDC) states that COVID-19
testing may be performed on patients with a doctor's approval.
· Current
testing is available through the CDC and is being offered at no
cost.
· A commercial
test for COVID-19 is also now available through Laboratory
Corporation of America (LabCorp) and Quest Diagnostics (Quest).
· All
suspected COVID-19 specimens will be collected at by health care
professionals such as physician offices and hospitals and sent to
the laboratories of LabCorp or Quest. Specimens for the
commercial test will not be collected directly at LabCorp or
Quest locations.
· Procedure
codes for health care providers and hospitals are expected to be
available April 1, 2020.